Principal Securities, Inc. Astrazeneca PLC Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Principal Securities, Inc. holds 46,495 shares of AZN stock, worth $3.93 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
46,495
Previous 28,053
65.74%
Holding current value
$3.93 Million
Previous $1.84 Billion
76.77%
% of portfolio
0.06%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,416Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.39 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.48 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.9 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.65 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.63 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $262B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...